413P Butyrylcholinesterase as a predictive marker for wound infection in elective colorectal cancer surgery

Surgical site infection (SSI) remains a frequent complication of elective colorectal cancer surgery. Butyrylcholinesterase (BChE), which is a cholinesterase enzyme synthesized in the liver, decreases in many clinical conditions such as liver damage, malnutrition, injury, and inflammation. The purpose of this study was to evaluate the efficacy of BChE as a tool for the diagnosis of SSI in elective operations for colorectal cancer.